Chief Executive Officer

As a single company, INC and inVentiv will offer end-to-end solutions to support drug development and commercialization. (Image: iStock/AndreyPopov)

INC Research, inVentiv merger 'a perfect fit'

By Melissa Fassbender

INC Research and inVentiv Health are merging to create one of the largest biopharmaceutical outsourcing providers – and a “top three CRO,” says CEO.

The acquisition is the latest in a series. (Image: iStock)

Charles River acquires analytical CRO

By Melissa Fassbender

Charles River Laboratories has acquired Blue Stream Laboratories, expanding the company’s biologic and biosimilar development capabilities.

FDA announces Quality head

PEOPLE ON THE MOVE

FDA announces Quality head

By Fiona BARRY

Plus PhRMA appoints chief executive, and more people news in this week's gallery.

Kaare Schultz resigned from Novo Nordisk today

PEOPLE ON THE MOVE

Favourite for Novo Nordisk CEO suddenly quits

By Fiona BARRY

Kaare Schultz, Novo Nordisk Chief Operating Officer and planned successor as Chief Executive, resigned unexpectedly today. Plus FDA's ex-top scientist heads up US Pharmacopoeia.

People on the move: Jobs in Pharma

People on the move: Jobs in Pharma

By Dan Stanton

In-PharmaTechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals.

Alcan acquires rest of Propack

Alcan acquires rest of Propack

By Wai Lang Chu

Alcan has acquired the outstanding minority share of Propack in a
deal that further cements the company's standing in the Chinese
market. The acquisition forms part of a major restructuring
exercise, in which the closure and...

Evotec Q3 down from 2003

Evotec Q3 down from 2003

German biotech company Evotec OAI posted decreased third quarterly
revenues of €16.1 million, down 26 per cent compared to 2003.
Evotec's performance reflects the difficult operating environment
for companies supplying drug discovery...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All